Department of Vascular Surgery and Organ Transplant Unit, University Hospital of Catania, Catania, Italy.
Institute for Vascular Research, St Franziskus Hospital, Münster, Germany.
PLoS One. 2022 Feb 24;17(2):e0264327. doi: 10.1371/journal.pone.0264327. eCollection 2022.
A growing number of abdominal aortic aneurysms with severe angulated neck anatomy is treated by endovascular means. However, contradictory early and late outcomes have been reported. Our review and outcome analysis attempted to evaluate the available literature and provide clinicians with a base for clinical implementation and future research.
A systematic review of the literature was undertaken to identify the outcomes of endovascular aneurysm repair in patients with severe infrarenal neck angulation (SNA ≥ 60°) vs non-severe neck angulation (NSNA). Outcome measures included perioperative complications, type 1a endoleak, neck-related secondary procedures, stent graft migration, aneurysm rupture, increase (>5mm) in sac diameter, all-cause and aneurysm-related mortality (PROSPERO Nr.: CRD42021233253).
Six observational studies reporting on 5981 patients (1457 with SNA and 4524 with NSNA) with a weighted mean follow-up period of 1.8 years were included. EVAR in SNA compared with NSNA was associated with a higher rate of type 1a endoleak at 30 days (4.0% vs 1.8%; p< 0.00001), at 1 year (2.8% vs 1.9%; p<0.03), at 2 years (4.9% vs 2.1%; p< 0.0002), at 3 years (5.6% vs 2.6%; p< 0.0001). The rate of neck-related secondary procedures was significantly higher at 1 year (6.6% vs 3.9%; p<0.05) and at 3 years (13.1% vs 9%; p<0.05). Graft migration, aneurysm sack increase, aneurysm rupture and all-cause mortality were not statistically different at mid-term.
The use of EVAR in severely angulated infrarenal aortic necks is associated with a high rate of early and mid-term complications. However, aortic related and all-causes mortality are not higher compared to patients with NSNA. Therefore, EVAR should be cautiously used in patients with SNA.
越来越多严重血管弯曲颈解剖学的腹主动脉瘤通过血管内方式进行治疗。然而,早期和晚期的结果报告存在矛盾。我们的回顾和结果分析试图评估现有文献,并为临床医生提供临床实施和未来研究的基础。
系统地回顾了文献,以确定在严重肾下颈角度(SNA≥60°)与非严重颈角度(NSNA)患者中血管内动脉瘤修复的结果。结果测量包括围手术期并发症、1a 型内漏、与颈部相关的继发性手术、支架移植物迁移、动脉瘤破裂、囊直径增加(>5mm)、全因和动脉瘤相关死亡率(PROSPERO 编号:CRD42021233253)。
纳入了 6 项观察性研究,共报告了 5981 例患者(1457 例 SNA 和 4524 例 NSNA),加权平均随访时间为 1.8 年。与 NSNA 相比,SNA 中的 EVAR 与 30 天时更高的 1a 型内漏率相关(4.0%比 1.8%;p<0.00001)、1 年时(2.8%比 1.9%;p<0.03)、2 年时(4.9%比 2.1%;p<0.0002)、3 年时(5.6%比 2.6%;p<0.0001)。与颈部相关的继发性手术率在 1 年时(6.6%比 3.9%;p<0.05)和 3 年时(13.1%比 9%;p<0.05)显著更高。中期时移植物迁移、动脉瘤囊增加、动脉瘤破裂和全因死亡率没有统计学差异。
在严重血管弯曲的肾下主动脉颈部使用 EVAR 与高发生率的早期和中期并发症相关。然而,与 NSNA 患者相比,主动脉相关和全因死亡率并不更高。因此,应谨慎在 SNA 患者中使用 EVAR。